首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   48147篇
  免费   2604篇
  国内免费   889篇
耳鼻咽喉   585篇
儿科学   779篇
妇产科学   1629篇
基础医学   2152篇
口腔科学   755篇
临床医学   5160篇
内科学   12476篇
皮肤病学   227篇
神经病学   1169篇
特种医学   856篇
外国民族医学   2篇
外科学   8760篇
综合类   6885篇
一般理论   1篇
预防医学   3212篇
眼科学   1021篇
药学   3448篇
  106篇
中国医学   1573篇
肿瘤学   844篇
  2024年   25篇
  2023年   795篇
  2022年   1333篇
  2021年   2098篇
  2020年   2107篇
  2019年   1492篇
  2018年   1503篇
  2017年   1393篇
  2016年   1358篇
  2015年   1518篇
  2014年   3587篇
  2013年   3342篇
  2012年   2928篇
  2011年   3469篇
  2010年   2616篇
  2009年   2602篇
  2008年   2584篇
  2007年   2436篇
  2006年   2136篇
  2005年   1785篇
  2004年   1486篇
  2003年   1254篇
  2002年   954篇
  2001年   871篇
  2000年   661篇
  1999年   554篇
  1998年   408篇
  1997年   379篇
  1996年   318篇
  1995年   338篇
  1994年   336篇
  1993年   305篇
  1992年   313篇
  1991年   239篇
  1990年   205篇
  1989年   218篇
  1988年   210篇
  1987年   169篇
  1986年   139篇
  1985年   218篇
  1984年   156篇
  1983年   89篇
  1982年   129篇
  1981年   103篇
  1980年   79篇
  1979年   67篇
  1978年   68篇
  1977年   52篇
  1976年   34篇
  1975年   34篇
排序方式: 共有10000条查询结果,搜索用时 21 毫秒
1.
背景糖尿病心脏自主神经病变(DCAN)是糖尿病常见且严重的慢性并发症之一,但目前关于甲状腺功能与DCAN关系的研究报道较少。目的探讨亚临床甲状腺功能减退症(SCH)对DCAN的影响。方法选取2019年10月至2020年10月在首都医科大学附属北京友谊医院住院及门诊就诊的2型糖尿病患者564例。所有患者均完成Ewing试验。收集患者一般资料、体格检查结果、实验室检查结果,并依据Ewing试验评估并筛查DCAN。相关性分析采用Pearson相关分析和Spearman秩相关分析,采用多因素Logistic逐步回归分析探究2型糖尿病患者并发DCAN的影响因素。结果564例2型糖尿病患者中,129例并发DCAN(DCAN组),435例未并发DCAN(对照组),DCAN发生率为22.9%。2型糖尿病患者中合并SCH者84例(14.9%),DCAN组患者中合并SCH者36例(28.0%),对照组患者中合并SCH者48例(11.0%),DCAN组患者合并SCH患病率高于对照组(χ2=22.346,P<0.001)。2型糖尿病并发DCAN患者Valsalva试验动作期间最大R-R间距与最小R-R间距比值(VAL R-R比值)与糖尿病病程、糖化血红蛋白(HbA1c)、空腹血糖(FBG)、低密度脂蛋白胆固醇(LDL-C)、三酰甘油(TC)、超敏C反应蛋白(hs-CRP)、促甲状腺激素(TSH)、尿微量白蛋白/肌酐(UACR)呈负相关,与舒张压(DBP)呈正相关(P<0.05)。多因素Logistic逐步回归分析结果显示,SCH〔OR=1.717,95%CI(1.246,2.365)〕是2型糖尿病患者并发DCAN的独立影响因素(P<0.05)。结论2型糖尿病患者TSH水平与DCAN相关,且SCH是2型糖尿病患者并发DCAN的独立影响因素。  相似文献   
2.
目的 本文总结了近年来白细胞介素22 (interleukin 22, IL - 22)与糖尿病(diabetes mellitus,DM)发病关系的研究,希望能为DM的防治及病情评估提供较为可行的策略靶点。方法 本文资料来源于中国知网、PubMed等数据库,以IL - 22、糖尿病、胰岛素、糖异生等关键词进行检索得到。结果 IL - 22可增加胰岛素分泌、促进胰岛素信号转导及维持葡萄糖稳态,参与DM发生、发展及病情演变。结论 IL - 22可通过多个环节参与DM的发病及病情演变,以IL - 22为靶点对于防治DM具有重要参考价值。  相似文献   
3.
4.
目的探讨后路长节段内固定治疗老年Ⅳ型陈旧性症状性骨质疏松性胸腰椎骨折(CSOTLF)后近端交界性后凸(PJK)发生的相关危险因素。方法采用病例对照研究分析2013年1月至2018年6月西安交通大学附属红会医院收治的95例老年Ⅳ型CSOTLF患者临床资料,其中男32例,女63例;年龄60~85岁[(67.4±6.5)岁]。损伤节段:T1117例,T1237例,L130例,L211例。患者均接受后路长节段内固定术治疗。按照术后是否发生PJK,将患者分为PJK组(30例)和非PJK组(65例)。采用单因素分析患者性别、年龄、体重指数(BMI)、骨密度(BMD)、吸烟史、致伤原因、合并症、损伤节段、美国脊髓损伤协会(ASIA)分级及受伤至手术时间等一般资料;交界性后凸角(PJA)、矢状垂直偏移(SVA)、骨盆入射角-腰椎前凸角差值(PI-LL)、骨盆倾斜角(PT)及骶骨倾斜角(SS)等术前影像学资料;后方韧带复合体(PLC)损伤、近端固定椎(UIV)位置、远端固定椎(LIV)位置、固定节段数等手术基本资料与术后PJK发生的相关性。采用多因素Logistic回归分析与术后PJK发生的独立危险因素。结果单因素分析结果显示,年龄、BMI、BMD、术前PJA、术前SVA、术前PI-LL、PLC损伤、UIV位置、LIV位置、固定节段数与术后PJK发生有一定的相关性(P均<0.05),而性别、吸烟史、致伤原因、合并症、损伤节段、ASIA分级、受伤至手术时间、术前PT、术前SS与术后PJK发生不相关(P均>0.05)。多因素Logistic回归分析结果表明,年龄≥70岁(OR=32.28,95%CI 3.83~272.29,P<0.01)、BMI>28.0 kg/m2(OR=7.88,95%CI 1.63~37.99,P<0.01)、BMD T值<-3.5 SD(OR=20.84,95%CI 2.36~183.93,P<0.01)、术前PI-LL>20°(OR=13.30,95%CI 1.54~113.87,P<0.05)及PLC损伤(OR=13.98,95%CI 1.37~142.34,P<0.05)与术后PJK发生显著相关。结论年龄≥70岁、BMI>28.0 kg/m2、BMD T值<-3.5 SD、术前PI-LL>20°及PLC损伤是老年Ⅳ型CSOTLF患者行后路长节段内固定术后PJK发生的独立危险因素。术中应重视软组织保护和脊柱矢状位平衡恢复,术后应注意控制体重及抗骨质疏松治疗。  相似文献   
5.
ObjectivesInitial studies of individuals with coronavirus disease 2019 (COVID-19) revealed that obesity, diabetes and hypertension were associated with severe outcomes. Subsequently, some authors showed that the risk could vary according to age, gender, co-morbidities and medical history. In a nationwide retrospective cohort, we studied the association between these co-morbidities and patients' requirement for invasive mechanical ventilation (IMV) or their death.MethodsAll French adult inpatients with COVID-19 admitted during the first epidemic wave (February to September 2020) were included. When patients were diagnosed with obesity, diabetes or hypertension for the first time in 2020, these conditions were considered as incident co-morbidities, otherwise they were considered prevalent. We compared outcomes of IMV and in-hospital death according to obesity, diabetes and hypertension, taking age, gender and Charlson's co-morbidity index score (CCIS) into account.ResultsA total of 134 209 adult inpatients with COVID-19 were included, half of them had hypertension (n = 66 613, 49.6%), one in four were diabetic (n = 32 209, 24.0%), and one in four were obese (n = 32 070, 23.9%). Among this cohort, IMV was required for 13 596 inpatients, and 19 969 patients died. IMV and death were more frequent in male patients (adjusted oods ratio (aOR) 2.0, 95% CI 1.9–2.1 and aOR 1.5, 95% CI 1.4–1.5, respectively), IMV in patients with co-morbidities (aOR 2.1, 95% CI 2.0–2.2 for CCIS = 2 and aOR 3.0, 95% CI 2.8–3.1 for CCIS ≥5), and death in patients aged 80 or above (aOR 17.0, 95% CI 15.5–18.6). Adjusted on age, gender and CCIS, death was more frequent among inpatients with obesity (aOR 1.2, 95% CI 1.1–1.2) and diabetes (aOR 1.2, 95% CI 1.1–1.2). IMV was more frequently necessary for inpatients with obesity (aOR 1.9, 95% CI 1.8–2.0), diabetes (aOR 1.4, 95% CI 1.3–1.4) and hypertension (aOR 1.7, 95% CI 1.6–1.8). Comparatively, IMV was more often required for patients with the following incident co-morbidities: obesity (aOR 3.5, 95% CI 3.3–3.7), diabetes (aOR 2.0, 95% CI 1.8–2.1) and hypertension (aOR 2.5, 95% CI 2.4–2.6).ConclusionsAmong 134 209 inpatients with COVID-19, mortality was more frequent among patients with obesity and diabetes. IMV was more frequently necessary for inpatients with obesity, diabetes and hypertension. Patients for whom these were incident co-morbidities were particularly at risk. Specific medical monitoring and vaccination should be priorities for patients with these co-morbidities.  相似文献   
6.
黎淑玲  刘俊杰  蒋邦好  罗劲根 《安徽医学》2022,43(11):1264-1267
目的 观察痔上动脉结扎(HAL)术对中重度混合痔患者的手术效果及对术后并发症的影响。方法 选取2019年6月至2020年6月广州市番禺区中心医院收治的148例混合痔合并出血性内痔患者作为研究对象,采用随机数字表法分为对照组与观察组,每组74例。对照组行痔上黏膜环切术(PPH)术,观察组行PPH联合HAL。观察比较两组患者手术时间、住院时间、住院费用,术后急性尿潴留,术后3个月内出血、脱垂、水肿、肛门狭窄、视觉疼痛模拟评分(VAS)、Wexner肛门失禁评分、疗效等指标的差异。结果 观察组手术时间较对照组更长,住院时间较对照组更短,住院费用较对照组更低,差异有统计学意义(P<0.05)。观察组术后出血比例为5.41%、水肿发生率为9.46%、Wexner肛门失禁评分为(2.32±1.25)分,均低于对照组,差异有统计学意义(P<0.05);观察组有效率为94.59%,高于对照组,差异有统计学意义(P<0.05)。手术后,两组VAS评分均降低,术后观察组VAS低于对照组,差异有统计学意义(P<0.05)。观察组术后急性尿潴留、脱垂、肛门狭窄发生情况与对照组比较,差异无统计学意义(P>0.05)。结论 PPH联合直视下HAL治疗出血性中重度混合痔安全有效,并发症发生率更低,具有临床应用价值。  相似文献   
7.
8.
IntroductionSurgery is the cornerstone of the treatment for advanced ovarian cancer. Reaching complete cytoreduction resulting in no gross residual disease often requires complex surgery. The aim of this study was to assess the impact of increased surgical radicality on the risk of complications in the treatment of advanced ovarian cancer.Materials and methodsAll consecutive patients with advanced ovarian cancer (FIGO Stage IIIB-IVB) who had undergone primary or interval debulking surgery during a six-year study period were identified. In the midst of the study period, a surgical practice change towards maximal surgical effort occurred. Two groups were formed for the analysis: cohort A, that consisted of patients operated before the surgical paradigm shift and cohort B, that consisted of patients operated under the period of increased surgical radicality.Results252 patients were included in the analysis. Complete resection (R0) was achieved in 21.3% of surgeries in cohort A and in 51.2% in cohort B. The total postoperative complication rate was 76.2%. Most of the complications (86.5%) were minor (Clavien-Dindo I-IIIA). The patients in cohort B were at increased risk for complications, OR 2.94 (95%CI 1.58–5.47; p = 0.001). As for the approach to cytoreduction (primary vs. interval debulking), there was no statistically significant association with the occurrence of postoperative complications (p = 0.659).ConclusionIn the present study more extensive surgeries led to better surgical results but increased postoperative morbidity. Postoperative complication rates were similar in both primary and interval debulking surgeries.  相似文献   
9.
Study objectiveTo evaluate the hysteroscopic findings in female genital tuberculosis.DesignIt was a prospective study of hysteroscopic findings performed on 348 cases of female genital tuberculosis (FGTB).SettingIt was a prospective cross-sectional study in a tertiary referral centre.PatientsA total of 348 patients with infertility with FGTB on various tests.InterventionA total of 348 patients of infertility found to have FGTB on various investigations were enrolled in the study. A detailed history was taken. Clinical examination, endometrial sampling and diagnostic laparoscopy were performed was also performed in selected cases. All patients underwent hysteroscopy as part of evaluation for infertility and tuberculosis (TB) findings.Measurements and main resultsThe mean age, parity, body mass index and duration of infertility was 28.2 years, 0.31,23.1kg/m2 and 3.44 years respectively. Infertility was primary in 81.03% and secondary in 18.96% cases. Diagnosis of FGTB was made by endometrial aspirate findings of positive AFB on microscopy (4.02%), positive culture (4.88%), positive PCR (83.90%), epithelioid granuloma (14.65%), positive AFB on microscopy or culture of peritoneal cytology (1.14%) or epithelioid granuloma on peritoneal biopsy (1.72%), definitive findings of TB on laparoscopy (41.95%) or probable findings of TB on laparoscopy (58.05%). Various hysteroscopic findings observed were normal findings (28.16%), pale endometrial cavity (54.31%), features of active TB (7.47%), features of chronic TB (19.54%), features of TB sequelae like obstructed ostia (both ostia in 13.79%, one ostia 14.94%, periostial fibrosis; (bilateral 4.59%, unilateral 5.17%), endometrial glands atrophy (12.35%), small shrunken cavity (6.32%), distorted cavity (5.17%), various grades of intrauterine adhesions (29.88%). Hysteroscopy in FGTB was associated with increased difficulties and complications like failed procedures, difficult visualisation, false passage and uterine perforation.ConclusionHysteroscopy is useful modality to detect endometrial TB but is associated with increased difficulty and complications.  相似文献   
10.
目的探究门冬胰岛素联合吡格列酮二甲双胍治疗糖尿病患者的临床效果及安全性。方法 90例糖尿病患者,采取随机数字表法分为观察组与对照组,各45例。对照组给予门冬胰岛素30治疗,观察组在对照组基础上加用吡格列酮二甲双胍治疗。对比两组治疗前后的血糖相关指标、胰岛素用量、不良反应发生率。结果治疗后,观察组空腹血糖(5.66±1.09)mmol/L、餐后2 h血糖(9.80±1.97)mmol/L、糖化血红蛋白(6.40±1.15)%均低于对照组的(8.57±1.25)mmol/L、(15.43±3.09)mmol/L、(7.85±1.27)%,差异有统计学意义(P<0.05)。观察组治疗期间胰岛素用量(32.78±5.50)U少于对照组的(41.08±6.33)U,差异有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论门冬胰岛素联合吡格列酮二甲双胍治疗糖尿病患者可取得较好的降低血糖水平的目的,安全性高。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号